News

a no holds barred interview with the CTA and GCS

Key Implications from MHRA and FSA Statements

Key Takeaways from the FSA's Latest Letter

FSA CEO warns industry following board meeting

Novel Foods, how to determine the legality of a CBD product.

The CTA is delighted to announce the confirmation of a registered Co-ordinated Primary Authority Partnership with Oxfordshire Trading Standards.

At present there is no labelling requirement in place to state whether a product contains natural, or synthetically produced CBD.